<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-02-07 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-02-07/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-02-07"><meta property="og:description" content="ğŸ“… Daily Report - 2026-02-07 ä»Šæ—¥ç­›é€‰å‡º 51 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-02-07T00:00:00+00:00"><meta property="article:modified_time" content="2026-02-07T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week062026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-02-07"><meta itemprop=description content="ğŸ“… Daily Report - 2026-02-07 ä»Šæ—¥ç­›é€‰å‡º 51 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-02-07T00:00:00+00:00"><meta itemprop=dateModified content="2026-02-07T00:00:00+00:00"><meta itemprop=wordCount content="1918"><meta itemprop=keywords content="Research,Daily,Week062026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-02-07"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-02-07 ä»Šæ—¥ç­›é€‰å‡º 51 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-07</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-02-07T00:00:00Z>2026-02-07</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-02-07>ğŸ“… Daily Report - 2026-02-07</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>51</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯åœ¨è‚¿ç˜¤å¾®ç¯å¢ƒï¼ˆå¦‚ä¹³è…ºç™Œã€è‚ ä¸Šçš®ï¼‰åŠç¥ç»ç³»ç»Ÿï¼ˆå¦‚æµ·é©¬ã€è‚ ç¥ç»ç³»ç»Ÿï¼‰ç ”ç©¶ä¸­å±•ç°å‡ºå‰æ‰€æœªæœ‰çš„åˆ†è¾¨ç‡ï¼Œæ­ç¤ºäº†ç»†èƒé—´äº’ä½œå’Œå¼‚è´¨æ€§ã€‚miR-18aåœ¨é»‘è‰²ç˜¤æ²»ç–—è€è¯æœºåˆ¶ä¸­çš„ä½œç”¨è¢«é˜æ˜ï¼Œä¸ºé¶å‘æ²»ç–—æä¾›äº†æ–°æ€è·¯ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤å¼‚è´¨æ€§ä¸æ²»ç–—è€è¯ï¼šè§£æä¸‰é˜´æ€§ä¹³è…ºç™Œã€é»‘è‰²ç˜¤ã€è‚ç»†èƒç™Œç­‰è‚¿ç˜¤ä¸­ï¼Œç»†èƒå¼‚è´¨æ€§ã€å…ç–«ç»†èƒä»¥åŠè‚¿ç˜¤å¾®ç¯å¢ƒå¦‚ä½•é©±åŠ¨æ²»ç–—æŠµæŠ—ã€‚</li><li>ç»†èƒå¯å¡‘æ€§ä¸å¹²ç»†èƒç”Ÿç‰©å­¦ï¼šç ”ç©¶ä¸Šçš®ç»†èƒã€ç¥ç»å…ƒç­‰åœ¨å‘è‚²ã€è¡°è€å’Œç–¾ç—…ï¼ˆå¦‚è‚¿ç˜¤å‘ç”Ÿï¼‰è¿‡ç¨‹ä¸­çš„å»åˆ†åŒ–ã€é‡ç¼–ç¨‹åŠå¹²ç»†èƒå¾®ç¯å¢ƒè°ƒæ§ã€‚</li><li>ç¥ç»é€€è¡Œæ€§ç–¾ç—…æœºåˆ¶ï¼šé€šè¿‡å¤šç»„å­¦æ‰‹æ®µæ¢ç©¶é˜¿å°”èŒ¨æµ·é»˜ç—…ã€å¸•é‡‘æ£®ç—…ç­‰ç¥ç»é€€è¡Œæ€§ç–¾ç—…çš„å…±åŒç—…ç†æœºåˆ¶åŠæµ·é©¬ä½“æŸä¼¤ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>ç©ºé—´è½¬å½•ç»„å­¦ (Spatial Transcriptomics)</strong>ï¼šå®ç°ç»„ç»‡å†…ç»†èƒçš„é«˜åˆ†è¾¨ç‡åŸºå› è¡¨è¾¾åˆ†æï¼Œæ­ç¤ºå¾®ç¯å¢ƒå’Œç»†èƒç©ºé—´æ’å¸ƒå¯¹åŠŸèƒ½çš„å½±å“ã€‚</li><li><strong>å•ç»†èƒè½¬å½•ç»„å­¦ (scRNA-seq)</strong>ï¼šæ·±å…¥è§£æç»†èƒå±‚é¢çš„å¼‚è´¨æ€§ï¼Œè¯†åˆ«ç¨€æœ‰ç»†èƒäºšç¾¤åŠå…¶åœ¨ç–¾ç—…å‘ç”Ÿå‘å±•ä¸­çš„ä½œç”¨ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
é¦–æ¬¡ç»˜åˆ¶å‡ºé©±åŠ¨ç™Œç—‡ç”Ÿé•¿çš„å…³é”®åŸºå› çªå˜å…¨å›¾ï¼›æ–°å‹é¼»å–·ç–«è‹—å¯¹H5N1ç¦½æµæ„Ÿå±•ç°å¼ºæ•ˆä¿æŠ¤ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>ç™Œç—‡åŸºå› çªå˜æœºåˆ¶è§£æ</li><li>ç¦½æµæ„Ÿç—…æ¯’ç–«è‹—ç ”å‘</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å…¨é¢æµ‹è¯•å…³é”®åŸºå› çƒ­ç‚¹åŒºåŸŸçš„æ¯ä¸€ç§å¯èƒ½çªå˜</li><li>å¼€å‘æ–°å‹é¼»å–·å¼ç–«è‹—ä»¥åº”å¯¹äººé™…ä¼ æ’­é£é™©</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (49æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE294252 ç‚ç—‡å’Œæ¶ˆé€€ç¨‹åºæ€§é«“ç³»å›è·¯è°ƒæ§ä¸Šçš®æ€§å’Œé—´è´¨æ€§ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„æ²»ç–—è€è¯æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€inflammationã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Liqun Yu ; Xiang ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSingle-cell analysis of human triple-negative breast cancer revealed heterogeneous macrophage populations with opposing phenotypesâ€”pro-inflammatory and pro-resolution of inflammation. Paradoxically, both subsets accumulated in therapy-refractory residual tumors but showed inverse correlations across patients, suggesting mutually exclusive resistance mechanisms. Inflammatory macrophages localized preferentially to epithelial-like tumors, whereas pro-resolution macrophages were enriched in mesenchymal-like tumors. Mouse models faithfully recapitulated these patterns. After chemo-immunotherapy, mesenchymal-like tumors expanded pro-resolution macrophages through phagocytosis/efferocytosis, Ï‰-3 fatty-acid uptake, and resolvin production. Macrophage-secreted C1q emerged as a principal antagonist of T-cell function by targeting mitochondria and inducing metabolic dysfunction. By contrast, epithelial-like tumors accumulated inflammatory macrophages and neutrophils that produced prostaglandins via Ï‰-6 fatty-acid pathways. Knocking down ELOVL5â€”an elongase involved in Ï‰-3 and Ï‰-6 metabolismâ€”mitigated both neutrophil- and macrophage-mediated immunosuppression. These distinct axes, driven by dysregulated inflammation and resolution programs, converged to undermine therapy-induced immunosurveillance; however, targeting their shared upstream regulators may overcome these resistance mechanisms.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294252">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE318353 å•ç»†èƒè½¬å½•ç»„åˆ†ææ­ç¤ºäº†é»‘è‰²ç´ ç˜¤ä¸­ miR-18a ä»‹å¯¼çš„é¶å‘æ²»ç–—å’Œå…ç–«æ²»ç–—è€è¯æ€§çš„å¼‚è´¨æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:immuno(logy|therapy|suppression)ã€resistanceã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensIn melanoma, the knockout of miR-18a not only leads to resistance to monotherapy with BRAF inhibitors but also to combined therapy with BRAF and MEK inhibitors. This resistance is achieved by promoting the expression of YAP in the Hippo pathway. Additionally, the knockout of miR-18a results in high expression of THBS1-CD47, which causes T cell tolerance. miR-18a is regulated by hnRNPA1, and patients with low expression of miR-18a and hnRNPA1 have poorer Event-Free Survival (EFS).</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318353">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE315587 åŸä½ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºäº†è§’è†œç¼˜å¹²ç»†èƒå¾®ç¯å¢ƒå’Œçœ¼è¡¨ä¸Šçš®çš„æ–°æ ‡å¿—ç‰©</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lamia Nureen ; Antonietta Salerno ; Orazio Vittorio ; Nick Di GirolamoSeries Type : OtherOrganism : Mus musculusThe mammalian cornea is endowed with stem cells (SCs) that have lifelong regenerative activity for its stratified epithelium. The niche for these cells is the limbus, and damage to this microstructure or its SCs results in a blinding disease known as limbal stem cell deficiency (LSCD). Despite the numerous studies that employ single-cell RNA sequencing, the identity of these cells remains an enigma principally because their spatial positioning is lost upon dissociation from their repository, and their gene expression is altered upon exposure to physical and chemical stressors during procurement. Herein, these adversities were avoided by conducting spatial transcriptomic screening directly on corneal, limbal and conjunctival tissues. Differentially expressed genes in the limbus included Krt16 and Nkiras1 among 6 others, which play a role in maintaining stemness, epithelial organization, immune surveillance, and tumor suppression. Krt16 was dynamically expressed in the developing limbus, correlated with slow-cycling label-retaining limbal epithelia and was induced during corneal injury; observations consistent with marking functional SCs. Additionally, we established Nkiras1 as a novel maker of neutrophils in the limbal SC niche, and Alox12e as a specific marker of conjunctival epithelia. Because current gold standard treatments for LSCD include SC transplantation, our data will inform future studies in delivering a more reliable standard therapy which incorporates an identifiable SC population to improve clinical outcomes.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315587">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE288888 æµ·é©¬ç¡¬åŒ–ä¸æ­£å¸¸æµ·é©¬çš„ç©ºé—´è½¬å½•ç»„å­¦ã€ç»„ç»‡ç—…ç†å­¦å’Œç£å…±æŒ¯äºšåŒºåˆ†å‰²æ¯”è¾ƒï¼šä¸€é¡¹æ¦‚å¿µéªŒè¯ç ”ç©¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Samuel Guzman ; Ken Jones ; Saman HazanySeries Type : OtherOrganism : Homo sapiensDespite recent major advances in work-up and treatment of Drug Resistant Mesial Temporal Lobe Epilepsy (MTLE) with Hippocampal Sclerosis (HS), the underlying pathophysiology of this disease remains elusive. Depending on the type of HS, as defined by the histopathologic International League Against Epilepsy (ILAE), studies report variable post-surgical seizure freedom durations, with diverse underlying pathophysiology and gene expression. We here describe our initial experience with incorporating spatial transcriptomics along with Magnetic Resonance Imaging (MRI) and histopathology in a patient with Drug Resistant MTLE and HS compared to the hippocampus of an age-sex matched control case. Cases were assessed by MRI hippocampal subfields segmentation, neuropathology, and spatial transcriptomics to identify candidate genes that play a role in the biology of HS. A significant finding was a partial inhibition of the methyl-CpG-binding protein 2 (MeCP2) gene in all subfields of the hippocampus, which is important for neuronal survival and differentiation. Together, our results have shown the feasibility of hippocampal subfield segmentation on MRI and direct correlation with histology and spatial transcriptomics to identify key areas of gene dysregulation in epilepsy. These novel methods can be used to implement personalized medicine and discovery of new drug targets.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288888">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE288394 å»åˆ†åŒ–é©±åŠ¨çš„è‡´ç™Œå¹²æ€§ä¿ƒè¿›è‚ ä¸Šçš®ç»†èƒç»´æŒè‚¿ç˜¤çš„é€‚åº”æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€regex:onco(logy|logist|gene|genic)ã€regex:intestin(e|al)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kylee Zgeib ; Thompson Hui ; Atharva Inamdar ; Ansu Perekatt ; Simon Garcia ; Binfeng Lu ; Crysta Lim ; Shima Nejati ; Amartya Singh ; Zahra Hashemi ; Dahlia Matouba ; Christina LiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIntestinal tumors can arise either from mutations sustained in Lgr5âº stem cells (bottom-up) or through dedifferentiation of lineage-committed epithelial cells (top-down). Using a Smad4 loss-of-function and Î²-catenin gain-of-function mutant mouse model, we show that dedifferentiation-derived stem cells sustain tumorigenesis more effectively than mutant Lgr5âº cells in the endogenous crypts. Bulk and single-cell RNA sequencing revealed transcriptional reprogramming and the emergence of oncogenic villus-derived stem-like cells. Complementary in vivo and organoid studies suggest that dedifferentiation-derived oncogenic stem cells possess superior tumor-initiating and sustaining capacity</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288394">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE288393 sc-RNA-seq ç ”ç©¶æ­ç¤ºäº†å»åˆ†åŒ–è‚ ä¸Šçš®ç»†èƒçš„è‡´ç™Œé‡ç¼–ç¨‹ä¸ºå¼‚è´¨å¹²ç»†èƒçŠ¶æ€ [æ•°æ®é›† 1]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:onco(logy|logist|gene|genic)ã€RNA-seqã€regex:intestin(e|al)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kylee Zgeib ; Thompson Hui ; Atharva Inamdar ; Ansu Perekatt ; Crystal Lim ; Shima Nejati ; Binfeng Lu ; Simon Garcia ; Zahra Hashemi ; Amartya Sigh ; Dahlia Matouba ; Christina LiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIntestinal tumors can arise either from mutations sustained in Lgr5âº stem cells (bottom-up) or through dedifferentiation of lineage-committed epithelial cells (top-down). Using a Smad4 loss-of-function and Î²-catenin gain-of-function mutant mouse model, we show that dedifferentiation-derived stem cells sustain tumorigenesis more effectively than mutant Lgr5âº cells in the endogenous crypts. Bulk and single-cell RNA sequencing revealed transcriptional reprogramming and the emergence of oncogenic villus-derived stem-like cells. Complementary in vivo and organoid studies suggest that dedifferentiation-derived oncogenic stem cells possess superior tumor-initiating and sustaining capacity</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288393">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE313961 å†…çš®ç´ å’ŒCD44ä»‹å¯¼çš„å¼‚å‹ä¿¡å·ä¼ å¯¼ä»‹å¯¼è‚¿ç˜¤-åŸºè´¨ä¸²æ‰°å¹¶ä¿ƒè¿›è‚ç»†èƒç™Œçš„æ¶æ€§è¿›å±•</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€carcinoma</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Woobeen Jo ; Chanho Park ; Min Kim ; Chu-Sook Kim ; Jungsun Yoo ; Sahee Kim ; Jiseon Shin ; Hyun-Woo Rhee ; Jiyoung ParkSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThis study profiles gene expression changes in the human SK-Hep1 cell line, a mesenchymal-like liver-derived cell model, under conditions of differential sorafenib responsiveness. Bulk RNA sequencing was performed on sorafenib-sensitive (SS) and sorafenib-resistant (SR) cells treated with control siRNA (siCtrl), COL6A3 siRNA (siCOL6A3), or siCOL6A3 combined with recombinent endotrophin (rhETP). The data were generated to characterize transcriptional patterns associated with altered proliferation-and survival-related phenotypes across defined experimental conditions.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313961">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE303197 Dynamic Antigen Expression and Intrinsic CTL Resistance in HIV-1 Reservoir Clones</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šantigenã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Richard B Jones ; Alberto Herrera ; Paul ZumboSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiensReservoirs of clonally expanded CD4+ T-cells harboring rebound-competent HIV-1 proviruses persist lifelong during ART. Latency is considered the principal barrier to viral eradication and has resisted pharmacological reversal, yet it appears that sustained immune pressure may still erode reservoirs. Recent advances have yielded glimpses into these exceptionally rare reservoir-harboring cells, implicating intrinsic pro-survival properties in their persistence. Here, we isolate and characterize populations of authentic reservoir clones (ARCs) that robustly proliferate and accumulate while producing infectious virus, without overtly succumbing to viral cytopathic effects. At any given moment, only small fractions of ARCs expressed HIV-1 proteins, a state remarkably unperturbed by potent TCR stimulation or latency-reversing agents. Nevertheless, sustained co-culture with cytotoxic T-lymphocytes (CTL) revealed extensive time-integrated antigenic vulnerability, culling clonal expansion of some ARCs by >90%. Notably, one regulatory T-cell ARC displayed pronounced cell-intrinsic resistance to CTL â€“ a longstanding hypothesis we now directly demonstrate â€“ linked to low oxidative stress and reversed with desferoxamine, a hypoxic stress inducer and FDA-approved therapeutic. Overall, we provide novel insights into the vulnerabilities of reservoir clones to potent, sustained CTL pressure and highlight intrinsic resistance pathways as actionable therapeutic targets, opening opportunities for advancing immune-based HIV-1 cure strategies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303197">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE296017 ç™Œç—‡ã€åœ°å¡ç±³æ¾å’Œè¡°è€å¼•èµ·çš„éª¨éª¼è‚Œèç¼©ä¸»è¦ç”±ä¸åŒçš„ç¿»è¯‘åä¿®é¥°å¼•èµ·ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€aging</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Anna Stephan ; Yong-Dong Wang ; Fabio DemontisSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusGene expression changes induced by LrpprcP27A vs. LrpprcWT in skeletal muscle</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296017">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE217516 æ”¯æ°”ç®¡æ‰©å¼ æ‚£è€…æ”¯æ°”ç®¡è‚ºæ³¡çŒæ´—æ¶²ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Elza Evren ; Tim WillingerSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensBronchiectasis is a lung disease characterized by irreversible dilation of the large airways (bronchodilatation), which often causes recurrent airway infection and non-resolving inflammation. In this study, we performed single-cell RNA-sequencing (scRNA-seq) to determine the heterogeneity of immune cells in the airways of bronchiectasis patients.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217516">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 39 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨2æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ç§‘å­¦å®¶åˆšåˆšç»˜åˆ¶å‡ºäº†é©±åŠ¨ç™Œç—‡ç”Ÿé•¿çš„çªå˜å›¾è°±</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every possible mutation in a critical hotspot, they found that some changes barely boost cancer signals, while others supercharge them. When matched against real patient data, the map accurately predicted cancer behavior across tissues.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/02/260204121540.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>æ–°å‹é¼»è…”ç–«è‹—å¯¹H5N1ç¦½æµæ„Ÿæ˜¾ç¤ºå‡ºå¼ºå¤§çš„ä¿æŠ¤ä½œç”¨</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼švaccine</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šAs bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts to spread widely between people. A new nasal spray vaccine showed strong protection against H5N1 in animal tests, outperforming traditional flu shots. Because it targets the nose and lungs, it may prevent infection at the earliest stage.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/02/260204114343.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>cancer</td><td>7</td></tr><tr><td>resistance</td><td>6</td></tr><tr><td>RNA-seq</td><td>6</td></tr><tr><td>sequencing</td><td>5</td></tr><tr><td>epigenome</td><td>5</td></tr><tr><td>single-cell</td><td>4</td></tr><tr><td>tumor</td><td>3</td></tr><tr><td>spatial</td><td>3</td></tr><tr><td>aging</td><td>2</td></tr><tr><td>inflammation</td><td>2</td></tr><tr><td>scRNA</td><td>2</td></tr><tr><td>spatial transcriptomics</td><td>2</td></tr><tr><td>transcriptomics</td><td>2</td></tr><tr><td>transcriptome</td><td>2</td></tr><tr><td>regex:onco(logy</td><td>logist</td></tr><tr><td>regex:intestin(e</td><td>al)</td></tr><tr><td>pathway</td><td>1</td></tr><tr><td>carcinoma</td><td>1</td></tr><tr><td>metabolic</td><td>1</td></tr><tr><td>antigen</td><td>1</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (39æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311781">GSE311781 ç ”ç©¶å‘ç°ï¼Œå±€ç¶æ€§ç™½è´¨ç—…å˜å¯å¯¼è‡´ç°è´¨ç‚ç—‡ã€ç¥ç»å…ƒåŠŸèƒ½éšœç¢å’Œçªè§¦ä¸¢å¤±ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318581">GSE318581 è½¬ç§»æ€§æ¿€ç´ æ•æ„Ÿæ€§å‰åˆ—è…ºç™Œä¸Šçš®å¼‚è´¨æ€§çš„å•ç»†èƒè½¬å½•ç»„å›¾è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318354">GSE318354 miR-18a CRISPR æ•²é™¤é»‘è‰²ç´ ç˜¤çš„è½¬å½•ç»„åˆ†æé‰´å®šå‡ºä¸æ²»ç–—è€è¯æ€§å’Œ T ç»†èƒæ€ä¼¤ç›¸å…³çš„åŸºå› </a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289920">GSE289920 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [é¶å‘æ‰©å¢å­æµ‹åº II]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289257">GSE289257 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [RNA-Seq,2]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288948">GSE288948 å·¨å™¬ç»†èƒ Smad1 å¯¼è‡´æ¢—æ­»ååŠŸèƒ½éšœç¢ï¼ŒæŠ‘åˆ¶è¡€ç®¡ç”Ÿæˆè¶‹åŒ–å› å­è¡¨è¾¾ï¼Œå¹¶åˆºæ¿€ç»†èƒå¤–åŸºè´¨é‡å¡‘</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255561">GSE255561 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255195">GSE255195 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [é¶å‘æ‰©å¢å­æµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318477">GSE318477 ç§€ä¸½éšæ†çº¿è™«æ»è‚²å‘è‚²è¿‡ç¨‹ä¸­åŸºå› è¡¨è¾¾çš„é€šè·¯ç‰¹å¼‚æ€§é€šé“åŒ–å’Œå¯å¡‘æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303395">GSE303395 æ°§å›ºé†‡å—ä½“ GPR183 æ„ŸçŸ¥ä»£è°¢å¾®ç¯å¢ƒä¿¡å·ï¼Œä¿ƒè¿›å•æ ¸ç»†èƒåˆ†åŒ–ä¸ºç»„ç»‡é©»ç•™è‚ºå·¨å™¬ç»†èƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303039">GSE303039 Elevated levels of Ube2g1 in hematopoietic stem cells lead to segmental aging of the hematopoietic system</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298718">GSE298718 è§£ç èƒ¶è´¨æ¯ç»†èƒç˜¤ä¾µè¢­ï¼šè‚¿ç˜¤èšé›†ä½“ä¸­ç¯å¢ƒå’Œç»†èƒå‘¨æœŸæ•ˆåº”çš„å•ç»†èƒåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298406">GSE298406 ç¥ç»å‘ç”Ÿé˜¶æ®µè‚ ç¥ç»ç³»ç»Ÿç¥–ç»†èƒæŸ“è‰²è´¨å¯åŠæ€§åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297618">å¯¹8å‘¨é¾„KPPC WTã€MAP3K7ff KPPCå’ŒMAP3K7fwt KPPCå°é¼ èƒ°è…ºè‚¿ç˜¤è¿›è¡ŒGSE297618å•ç»†èƒRNAæµ‹åºåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318560">GSE318560 ç¥ç»é€€è¡Œæ€§ç—´å‘†ç—‡ï¼ˆé˜¿å°”èŒ¨æµ·é»˜ç—…ã€å”æ°ç»¼åˆå¾å’Œå¸•é‡‘æ£®ç—…ï¼‰æµ·é©¬ä½“çš„å…±åŒè‡´ç—…æœºåˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306150">GSE306150 ä¸»åŠ¨è„‰ç‚æ ·æœ¬çš„ç©ºé—´åŸºå› è¡¨è¾¾è°±åˆ†æã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300299">GSE300299 åŸºå­”è‚¯é›…ç—…æ¯’æŒç»­å­˜åœ¨äºå…³èŠ‚ç›¸å…³å·¨å™¬ç»†èƒä¸­ï¼Œå¹¶ä¿ƒè¿›æ…¢æ€§ç–¾ç—…çš„å‘ç”Ÿã€‚[scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318613">GSE318613 æ’æ²³çŒ´å¯¹ç–«è‹—çš„é€‚åº”æ€§å…ç–«ååº”åæ˜ äº†é¦–æ¬¡æ¥è§¦æ—¶çš„ç¤¾ä¼šåœ°ä½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318538">GSE318538 KIFC1æ•²ä½å¯¹H146å°ç»†èƒè‚ºç™Œç»†èƒåŸºå› è¡¨è¾¾çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318501">åŸºäº CRISPR ç­›é€‰çš„ GSE318501 miRNA-18a å¯è°ƒæ§é»‘è‰²ç´ ç˜¤ä¸­çš„é¶å‘æ²»ç–—è€è¯æ€§å’Œ T ç»†èƒæ€ä¼¤ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318414">GSE318414 æ—¥å…‰æ€§é›€æ–‘ä¸­è„‚è´¨ä»£è°¢ç´Šä¹±ï¼šå¤šç³»ç»Ÿæ°´å¹³åˆ†ææ­ç¤ºè†œä¸ç¨³å®šæ€§å’Œèƒ½é‡ç¨³æ€ç ´å</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318342">GSE318342 Snail1 é€šè¿‡ EGR1ã€FOXO1 å’Œ CEPBg è¯±å¯¼å¢æ®–æŠ‘åˆ¶ï¼Œä¸ºé¶å‘å‡‹äº¡å’Œç»†èƒè¡°è€é€šè·¯åˆ›é€ äº†è„†å¼±æ€§ [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318340">GSE318340 Snail1 é€šè¿‡ EGR1ã€FOXO1 å’Œ CEPBg è¯±å¯¼å¢æ®–æŠ‘åˆ¶ï¼Œä¸ºé¶å‘å‡‹äº¡å’Œç»†èƒè¡°è€é€šè·¯åˆ›é€ äº†è„†å¼±æ€§ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318318">GSE318318 BAF60Cåœ¨2å‹ç³–å°¿ç—…ä¸­çš„ä½œç”¨â€”â€”å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318308">GSE318308 ä¸€é¡¹ II æœŸæ¦‚å¿µéªŒè¯ç ”ç©¶ï¼Œè¯„ä¼°åº¦ä¼åˆ©å°¤å•æŠ—å’Œè¥¿åœ°å°¼å¸ƒè”åˆæˆ–ä¸è”åˆå¥¥æ‹‰å¸•å°¼æ²»ç–—å¤å‘æ€§åµå·¢ç™Œçš„ç–—æ•ˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318305">GSE318305 ç”˜æ°¨é…¸é€šè¿‡ GCN2/AKT è½´ä¿ƒè¿›å¿ƒè‚Œç»†èƒå¢æ®–å’Œå¿ƒè„å†ç”Ÿ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317978">GSE317978 BAF60Cåœ¨2å‹ç³–å°¿ç—…ä¸­çš„ä½œç”¨â€”â€”RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317708">GSE317708 BAF60C åœ¨ 2 å‹ç³–å°¿ç—…ä¸­çš„ä½œç”¨ â€”â€”ATAC-seq</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317461">GSE317461 CUET å¤„ç†çš„ç”²çŠ¶è…º 8505 ç»†èƒçš„ç‰¹å¾åˆ†æ (RNA-Seq)</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311046">GSE311046 ç¥ç»ç”Ÿé•¿å› å­ (NGF) é©±åŠ¨ ILC2 çš„ä¿ƒè‚¿ç˜¤åŠŸèƒ½ - äººç±» TRKA+ å’Œ TRKA- ILC2 çš„æ‰¹é‡ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291324">GSE291324 å¯¹ä½è‘¡è„ç³–æˆ– MAPKAPK2 è¡¨è¾¾ç¼ºå¤±çš„ HCT116 ç»†èƒè¿›è¡Œè½¬å½•ç»„åˆ†æã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291147">GSE291147 åˆ©ç”¨ PerturbFate ç»˜åˆ¶é»‘è‰²ç´ ç˜¤è€è¯æ€§çš„è¶‹åŒè°ƒæ§å› å­å›¾è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289256">GSE289256 é³çŠ¶ç»†èƒè‚ºç™Œçš„å¤šç»„å­¦å›¾è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289032">GSE289032 G1-APOL1 éª¨é«“åµŒåˆ B6 å°é¼ å’Œå®Œå…¨ MHC ä¸åŒ¹é…çš„å¼‚ä½å¿ƒè„ç§»æ¤æ’æ–¥ååº”ï¼ˆBALBc-to-B6 æ¨¡å‹ï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289030">GSE289030 BACè½¬åŸºå› G1-å’ŒG0-APOL1å°é¼ CD8+Tç»†èƒåœ¨ä½“å¤–åˆºæ¿€åçš„è½¬å½•ç»„ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282078">GSE282078 CAR-M2æ°´å‡èƒ¶æ²»ç–—å¯¹è‚¾çº¤ç»´åŒ–å°é¼ çº¤ç»´åŒ–å’Œå†…çš®è¡€ç®¡ç”Ÿæˆç­‰ç›¸å…³åŸºå› è¡¨è¾¾çš„å½±å“ï¼ˆæ‰¹é‡RNAæµ‹åºï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255194">GSE255194 å®šåˆ¶åŸºäº CRISPR/Cas çš„è¡¨è§‚åŸºå› ç»„ç¼–è¾‘å™¨ä»¥å®ç°å¯ç¼–ç¨‹æŸ“è‰²è´¨é…°åŒ–å’Œé™ä½ç»†èƒæ¯’æ€§ [CUT&amp;RUN]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248745">GSE248745 é€šè¿‡åŸä½ APEX2 é©±åŠ¨çš„ç”Ÿç‰©ç´ åŒ–å»ºç«‹åŸå§‹åµæ³¡é˜¶æ®µåµæ¯ç»†èƒè›‹ç™½è´¨ç»„åŠé¡ºé“‚è¯±å¯¼çš„å˜åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE173800">åˆ©ç”¨æ–°ä¸€ä»£æµ‹åºæŠ€æœ¯è¯„ä¼°AhRå¯¹å°é¼ è‚è„çš„å½±å“ï¼ˆGSE173800ï¼‰</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-06 21:49</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week062026/ rel=tag>Week062026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-02-06/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-06</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-02-08/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-08</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-20/>ç§‘ç ”æ—¥æŠ¥ 2026-02-20</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-19/>ç§‘ç ”æ—¥æŠ¥ 2026-02-19</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-18/>ç§‘ç ”æ—¥æŠ¥ 2026-02-18</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-17/>ç§‘ç ”æ—¥æŠ¥ 2026-02-17</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-16/>ç§‘ç ”æ—¥æŠ¥ 2026-02-16</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (113)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (113)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week072026/ title=Week072026>Week072026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>